157 related articles for article (PubMed ID: 23044454)
21. [THE FREQUENCIES AND MANAGEMENT OF ADVERSE REACTIONS IN MULTI-DRUG RESISTANT TUBERCULOSIS TREATMENT].
Sasaki Y; Yoshiyama T; Okumura M; Morimoto K; Miyamoto M; Irina ; Yoshimori K; Kurashima A; Ogata H; Gotoh H
Kekkaku; 2017 Jan; 92(1):11-19. PubMed ID: 30646468
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt.
Gadallah MA; Mokhtar A; Rady M; El-Moghazy E; Fawzy M; Kandil SK
J Formos Med Assoc; 2016 Nov; 115(11):997-1003. PubMed ID: 26696497
[TBL] [Abstract][Full Text] [Related]
23. Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea: A retrospective study.
Yang TW; Park HO; Jang HN; Yang JH; Kim SH; Moon SH; Byun JH; Lee CE; Kim JW; Kang DH
Medicine (Baltimore); 2017 Jul; 96(28):e7482. PubMed ID: 28700490
[TBL] [Abstract][Full Text] [Related]
24. Thyroid profile status of patients treated for multidrug-resistant tuberculosis in state of Meghalaya, India.
Saharia GK; Ruram AA; Lyngwa J
Indian J Tuberc; 2015 Jul; 62(3):166-70. PubMed ID: 26600329
[TBL] [Abstract][Full Text] [Related]
25. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
[TBL] [Abstract][Full Text] [Related]
27. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
[TBL] [Abstract][Full Text] [Related]
28. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
[TBL] [Abstract][Full Text] [Related]
29. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
[TBL] [Abstract][Full Text] [Related]
30. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
[TBL] [Abstract][Full Text] [Related]
31. Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana.
Zetola NM; Modongo C; Kip EC; Gross R; Bisson GP; Collman RG
Int J Tuberc Lung Dis; 2012 Nov; 16(11):1529-34. PubMed ID: 22963934
[TBL] [Abstract][Full Text] [Related]
32. Occurrence, Management, and Risk Factors for Adverse Drug Reactions in Multidrug Resistant Tuberculosis Patients.
Ahmad N; Javaid A; Syed Sulaiman SA; Afridi AK; Zainab ; Khan AH
Am J Ther; 2018; 25(5):e533-e540. PubMed ID: 26938643
[TBL] [Abstract][Full Text] [Related]
33. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
[TBL] [Abstract][Full Text] [Related]
34. Changes in treatment outcomes of multidrug-resistant tuberculosis.
Kwak N; Kim HR; Yoo CG; Kim YW; Han SK; Yim JJ
Int J Tuberc Lung Dis; 2015 May; 19(5):525-30. PubMed ID: 25868019
[TBL] [Abstract][Full Text] [Related]
35. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis.
Musso M; Mosti S; Gualano G; Mencarini P; Urso R; Ghirga P; Rianda A; Del Nonno F; Goletti D; Palmieri F
BMC Infect Dis; 2019 Oct; 19(1):882. PubMed ID: 31640579
[TBL] [Abstract][Full Text] [Related]
37. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
38. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
[TBL] [Abstract][Full Text] [Related]
39. Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation.
Miller AC; Gelmanova IY; Keshavjee S; Atwood S; Yanova G; Mishustin S; Furin JJ; Shin SS
Int J Tuberc Lung Dis; 2012 Jul; 16(7):891-6. PubMed ID: 22507895
[TBL] [Abstract][Full Text] [Related]
40. Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant Tuberculosis Regimen in a Rural Setting in Angola.
Aznar ML; Rando Segura A; Moreno MM; Espasa M; Sulleiro E; Bocanegra C; Gil Olivas E; Eugénio AN; Zacarias A; Katimba D; Gabriel E; Mendioroz J; López García MT; Pumarola T; Tórtola MT; Molina I
Am J Trop Med Hyg; 2019 Sep; 101(3):502-509. PubMed ID: 31333153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]